Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 1:18 PM
Ignite Modification Date:
2025-12-26 @ 1:18 PM
NCT ID:
NCT02481206
Brief Summary:
A multi-center, prospective, randomized controlled clinical trial with 1:1 assignment of treatment and control. This study will evaluate the impact of wearable cardioverter defibrillator use on sudden cardiac death in incident hemodialysis patients. The study will enroll up to 2,600 subjects. A maximum of 200 sites in the USA will be used for enrollment.
Detailed Description:
Objective:
To study the impact of wearable cardioverter defibrillator (WCD) use on sudden cardiac death in hemodialysis patients.
Study Population:
Participants will be patients beginning hemodialysis (\<2 months from initiation) who are ≥ 50 years old.
Intervention:
A WCD will be used for protection against sudden cardiac death (SCD).
Study Design:
The study will be a multi-center, prospective, randomized controlled trial with 1:1 assignment of treatment and control.
Study Size:
The study will enroll up to 2,600 subjects. A maximum of 200 sites will be used for enrollment.
Study:
NCT02481206
Study Brief:
Protocol Section:
NCT02481206